Phase II trial of single agent bortezomib (VELCADE (R)) in patients with previously untreated multiple myeloma (MM) Meeting Abstract


Authors: Richardson, P. G.; Chanan-Khan, A.; Schlossman, R. L.; Munshi, N. C.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A. L.; Lonial, S.; Hassoun, H.; Doss, D.; Colson, K.; McKenney, M.; Hande, K.; Koryzna, A.; Stoklas, B.; Lunde, L.; Gorelik, S.; McAlister, C.; Freeman, A.; Warren, D.; Collins, D.; Esseltine, D.; Amato, A.; Anderson, K. C.
Abstract Title: Phase II trial of single agent bortezomib (VELCADE (R)) in patients with previously untreated multiple myeloma (MM)
Meeting Title: 46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 104
Issue: 11 Pt. 1
Meeting Dates: 2004 Dec 4-7
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2004-11-16
Start Page: 100A
Language: English
ACCESSION: WOS:000225127500338
PROVIDER: wos
PUBMED: 15562524
Notes: Meeting Abstract: 336 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos
MSK Authors
  1. Hani Hassoun
    146 Hassoun